Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | Mannose-modified lipid nanoparticle loaded with citraconic acid |
| Catalog Number | LNP-058 |
| Size | 10 mg; 20 mg; 50 mg |
| Alias | MAN-LNP@citraconic acid; Lucose-modified lipid nanoparticles@citraconic acid |
| Appearance | Dispersion |
| Solubility | Ethanol, dimethyl sulfoxide |
| Description | MAN-LNP@citraconic acid is a new composite system that combines mannose-modified lipid nanoparticles with citraconic acid. Lipid nanoparticles (LNP)have good biocompatibility and drug-loading capacity, and can effectively package nucleic acids, small molecule drugs, etc. The modification of mannose (MAN)enables the system to specifically recognize the mannose receptor on the cell surface, thereby achieving targeted delivery and improving the enrichment efficiency of the drug in the target tissue or target cells. |
| Applications | Gene delivery |
| Storage | 2-8°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 Year |
| Shipping Condition | Low temperature transport |